This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Outcomes of Delivery in Patients With Dyspareunia

This study has been completed.
Information provided by (Responsible Party):
Hadassah Medical Organization Identifier:
First received: December 12, 2012
Last updated: October 10, 2016
Last verified: October 2016
The focus of this pilot study is to determine if a woman who experiences pain during sexual intercourse has a higher risk of complications during labor and delivery secondary to pelvic floor dysfunction, anxiety and intolerance towards pelvic examinations. Furthermore, it is unclear whether women with prepartum dyspareunia experience an improvement following vaginal delivery. While physicians may expect that vaginal birth improves dyspareunia due to the stretching effect on pelvic floor, to date, there is insufficient evidence to support this claim. The Investigators plan to prospectively study 200 patients at our Institution, collect information regarding birth and follow them, via questionnaires, regarding their dyspareunia postpartum.

Dyspareunia Pregnancy Provoked Vestibulodynia Pelvic Floor Dysfunction

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Outcomes of Delivery in Patients With Dyspareunia- A Prospective Study

Resource links provided by NLM:

Further study details as provided by Hadassah Medical Organization:

Primary Outcome Measures:
  • Obstetrical outcome of women with a history of dyspareunia [ Time Frame: 3 months -1 year ]
    The Investigators will record the mode of delivery (vaginal, instrumental or cesarean section), length of the second stage of labor, use of anesthetics, perineal tears and\or episiotomies, and newborn's birth weight. The evaluation will be done prospectively, comparing data with matched controls without a history of dyspareunia.

Secondary Outcome Measures:
  • Rate of alleviation of dyspareunia following vaginal delivery as assessed through patient questionnaires. [ Time Frame: 2 years ]

Enrollment: 173
Study Start Date: January 2013
Study Completion Date: September 2016
Primary Completion Date: September 2016 (Final data collection date for primary outcome measure)
Definite diagnosis of dyspareunia
Patients who report dyspareunia, and whose dyspareunia was evaluated prior to delivery by a caregiver experienced with sexual pain disorders, with definite diagnosis.
No definite diagnosis of dyspareunia
Patients who report dyspareunia but were not evaluated prior to delivery or were evaluated inappropriately (i.e. "yeast infection" without cultures, "inflammation" and other vague definitions).
Patients without dyspareunia
Patients without dyspareunia- those who report non painful sexual intercourse. This group of patients will be used as a control group.


Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Nulliparous women admitted to the Labor and Delivery Department at the Hadassah Medical Center, above the age of 18

Inclusion Criteria:

  1. 200 nulliparous women admitted to the Labor and Delivery Department at the Hadassah Medical Center, above the age of 18.
  2. Able and willing to read, understand, and sign the Informed Consent Form and questionnaire.
  3. Agree to be contacted in the future to complete telephone questionnaires.

Exclusion Criteria:

  1. Induction of labor
  2. Placental abruption, placenta previa
  3. Malpresentation
  4. Non reassuring fetal heart rate upon admission
  5. Any other contraindication for vaginal delivery
  6. Multifetal pregnancy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01753258

Hadassah Medical Organization
Jerusalem, Israel
Sponsors and Collaborators
Hadassah Medical Organization
Principal Investigator: Ahinoam Lev-Sagie, MD Hadassah Medical Organization
  More Information

Responsible Party: Hadassah Medical Organization Identifier: NCT01753258     History of Changes
Other Study ID Numbers: Delivery-Dyspareunia-HMO-CTIL
Study First Received: December 12, 2012
Last Updated: October 10, 2016

Additional relevant MeSH terms:
Vulvar Vestibulitis
Sexual Dysfunction, Physiological
Genital Diseases, Male
Genital Diseases, Female
Sexual Dysfunctions, Psychological
Mental Disorders
Vulvar Diseases
Vulvitis processed this record on September 21, 2017